Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for MIRA Pharmaceuticals, Inc. (MIRA : NSDQ)

• Company Description    MIRA Pharmaceuticals Inc. operates as a clinical development stage biopharmaceutical company. The company focuses on the development and commercialization of a new molecular synthetic tetrahydrocannabinol analog under investigation for the treatment of adult patients with anxiety and cognitive decline typically associated with early-stage dementia. MIRA Pharmaceuticals Inc. is based in Baltimore, Maryland. Number of Employees: 2

• Price / Volume Information    Yesterday's Closing Price: $0.99 Daily Weekly Monthly 20 Day Moving Average: 112,795 shares Shares Outstanding: 42.02 (millions) Market Capitalization: $41.69 (millions) Beta: 1.48 52 Week High: $2.45 52 Week Low: $0.90 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week -5.52% -10.14% 12 Week -25.41% -31.05% Year To Date -34.30% -39.84%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 1200 BRICKELL AVENUE SUITE 1950 #1183 - MIAMI,FL 33131 USA ph: 786-432-9792 fax: - info@mirapharma.com https://mirapharmaceuticals.com

• General Corporate Information    Officers Erez Aminov - Chief Executive Officer and Chairman Alan Weichselbaum - Chief Financial Officer Matthew Whalen - Director Matthew Del Giudice - Director Denil Shekhat - Director Peer Information - (-) - (-) - (-) - (-) - (-) - (-) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MED-BIOMED/GENE Sector: Medical CUSIP: 60458C104 SIC: 2834 Fiscal Year Fiscal Year End: December Last Reported Quarter: 03/01/26 Next Expected EPS Date: 08/13/26 Share - Related Items Shares Outstanding: 42.02 Most Recent Split Date: (:1) Beta: 1.48 Market Capitalization: $41.69 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $ Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $ Payout Ratio: Number of Estimates in the Fiscal Year Consensus: Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: 08/13/26

• Fundamental Ratios P/E Current FY Estimate: - Trailing 12 Months: - PEG Ratio: - Price Ratios Price/Book: 4.46 Price/Cash Flow: - Price / Sales: - EPS Growth vs. Year Ago Period: 72.73% vs. Previous Quarter: -% Sales Growth vs. Year Ago Period: -% vs. Previous Quarter: -% ROE 03/31/26 - -140.82 12/31/25 - -210.90 09/30/25 - -236.29 ROA 03/31/26 - -135.01 12/31/25 - -198.94 09/30/25 - -213.97 Current Ratio 03/31/26 - 82.15 12/31/25 - 15.75 09/30/25 - 90.53 Quick Ratio 03/31/26 - 82.15 12/31/25 - 15.75 09/30/25 - 90.53 Operating Margin 03/31/26 - - 12/31/25 - - 09/30/25 - - Net Margin 03/31/26 - - 12/31/25 - - 09/30/25 - - Pre-Tax Margin 03/31/26 - - 12/31/25 - - 09/30/25 - - Book Value 03/31/26 - 0.22 12/31/25 - 0.25 09/30/25 - 0.19 Inventory Turnover 03/31/26 - - 12/31/25 - - 09/30/25 - - Debt-to-Equity 03/31/26 - 0.00 12/31/25 - 0.00 09/30/25 - 0.00 Debt-to-Capital 03/31/26 - 0.00 12/31/25 - 0.00 09/30/25 - 0.00

Powered by Zacks Investment Research ©